21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients
Xagara, A., Fortis, S., Goulielmaki, M., Koinis, F., Chantzara, E., Samaras, I., Papadopoulos, V.N., Georgoulias, V., Baxevanis, C.N., Kotsakis, A.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article